Catelani Michael bought ANIX
September 30, 2026 · Form 4 insider transaction
Catelani Michael bought 5,500 shares of Anixa Biosciences, Inc. at $2.84 per share, a transaction worth $15.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,500
Price
$2.84
Total value
$15.6K
InsiderCatelani Michael
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 30, 2026
Filing dateSeptember 30, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo